Report cover image

Fertility Epigenetic Benchmarking Market Forecasts to 2032 – Global Analysis By Component (Products and Services), Technology (DNA Methylation, Histone Modification and RNA Sequencing), Application, End User and By Geography

Published Sep 15, 2025
Length 200 Pages
SKU # SMR20398566

Description

1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Fertility Epigenetic Benchmarking Market, By Component
5.1 Introduction
5.2 Products
5.2.1 Kits and Reagents
5.2.2 Instruments and Accessories
5.3 Services
5.3.1 DNA Methylation Analysis
5.3.2 Histone Modification Analysis
5.3.3 Non-coding RNA Analysis
5.3.4 Chromatin Structure Analysis
6 Global Fertility Epigenetic Benchmarking Market, By Technology
6.1 Introduction
6.2 DNA Methylation
6.2.1 Bisulfite Sequencing
6.2.2 Methylated DNA Immunoprecipitation Sequencing (MeDIP-Seq)
6.2.3 Other DNA Methylation Technologies
6.3 Histone Modification
6.3.1 Chromatin Immunoprecipitation (ChIP)
6.3.2 Histone Methylation Analysis
6.3.3 Histone Acetylation Analysis
6.4 RNA Sequencing
7 Global Fertility Epigenetic Benchmarking Market, By Application
7.1 Introduction
7.2 Male Infertility
7.3 Female Infertility
7.4 Assisted Reproductive Technology (ART)
7.4.1 In Vitro Fertilization (IVF)
7.4.2 Intracytoplasmic Sperm Injection (ICSI)
7.4.3 Preimplantation Genetic Testing (PGT)
7.5 Predictive Diagnostics and Prognostics
8 Global Fertility Epigenetic Benchmarking Market, By End User
8.1 Introduction
8.2 Fertility Clinics and Hospitals
8.3 Academic and Research Institutes
8.4 Pharmaceutical and Biotechnology Companies
8.5 Diagnostic Laboratories
8.6 Contract Research Organizations (CROs)
9 Global Fertility Epigenetic Benchmarking Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Illumina
11.2 Thermo Fisher Scientific
11.3 Merck KGaA
11.4 QIAGEN
11.5 F. Hoffmann-La Roche
11.6 PacBio
11.7 Danaher
11.8 Bio-Rad Laboratories
11.9 Promega
11.10 New England Biolabs
11.11 Zymo Research
11.12 Hologic
11.13 Active Motif
11.14 Chroma Medicine
11.15 CooperSurgical
11.16 Inherent Biosciences
11.17 Vitrolife
11.18 Ferring Pharmaceuticals
List of Tables
Table 1 Global Fertility Epigenetic Benchmarking Market Outlook, By Region (2024-2032) ($MN)
Table 2 Global Fertility Epigenetic Benchmarking Market Outlook, By Component (2024-2032) ($MN)
Table 3 Global Fertility Epigenetic Benchmarking Market Outlook, By Products (2024-2032) ($MN)
Table 4 Global Fertility Epigenetic Benchmarking Market Outlook, By Kits and Reagents (2024-2032) ($MN)
Table 5 Global Fertility Epigenetic Benchmarking Market Outlook, By Instruments and Accessories (2024-2032) ($MN)
Table 6 Global Fertility Epigenetic Benchmarking Market Outlook, By Services (2024-2032) ($MN)
Table 7 Global Fertility Epigenetic Benchmarking Market Outlook, By DNA Methylation Analysis (2024-2032) ($MN)
Table 8 Global Fertility Epigenetic Benchmarking Market Outlook, By Histone Modification Analysis (2024-2032) ($MN)
Table 9 Global Fertility Epigenetic Benchmarking Market Outlook, By Non-coding RNA Analysis (2024-2032) ($MN)
Table 10 Global Fertility Epigenetic Benchmarking Market Outlook, By Chromatin Structure Analysis (2024-2032) ($MN)
Table 11 Global Fertility Epigenetic Benchmarking Market Outlook, By Technology (2024-2032) ($MN)
Table 12 Global Fertility Epigenetic Benchmarking Market Outlook, By DNA Methylation (2024-2032) ($MN)
Table 13 Global Fertility Epigenetic Benchmarking Market Outlook, By Bisulfite Sequencing (2024-2032) ($MN)
Table 14 Global Fertility Epigenetic Benchmarking Market Outlook, By Methylated DNA Immunoprecipitation Sequencing (MeDIP-Seq) (2024-2032) ($MN)
Table 15 Global Fertility Epigenetic Benchmarking Market Outlook, By Other DNA Methylation Technologies (2024-2032) ($MN)
Table 16 Global Fertility Epigenetic Benchmarking Market Outlook, By Histone Modification (2024-2032) ($MN)
Table 17 Global Fertility Epigenetic Benchmarking Market Outlook, By Chromatin Immunoprecipitation (ChIP) (2024-2032) ($MN)
Table 18 Global Fertility Epigenetic Benchmarking Market Outlook, By Histone Methylation Analysis (2024-2032) ($MN)
Table 19 Global Fertility Epigenetic Benchmarking Market Outlook, By Histone Acetylation Analysis (2024-2032) ($MN)
Table 20 Global Fertility Epigenetic Benchmarking Market Outlook, By RNA Sequencing (2024-2032) ($MN)
Table 21 Global Fertility Epigenetic Benchmarking Market Outlook, By Application (2024-2032) ($MN)
Table 22 Global Fertility Epigenetic Benchmarking Market Outlook, By Male Infertility (2024-2032) ($MN)
Table 23 Global Fertility Epigenetic Benchmarking Market Outlook, By Female Infertility (2024-2032) ($MN)
Table 24 Global Fertility Epigenetic Benchmarking Market Outlook, By Assisted Reproductive Technology (ART) (2024-2032) ($MN)
Table 25 Global Fertility Epigenetic Benchmarking Market Outlook, By In Vitro Fertilization (IVF) (2024-2032) ($MN)
Table 26 Global Fertility Epigenetic Benchmarking Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2024-2032) ($MN)
Table 27 Global Fertility Epigenetic Benchmarking Market Outlook, By Preimplantation Genetic Testing (PGT) (2024-2032) ($MN)
Table 28 Global Fertility Epigenetic Benchmarking Market Outlook, By Predictive Diagnostics and Prognostics (2024-2032) ($MN)
Table 29 Global Fertility Epigenetic Benchmarking Market Outlook, By End User (2024-2032) ($MN)
Table 30 Global Fertility Epigenetic Benchmarking Market Outlook, By Fertility Clinics and Hospitals (2024-2032) ($MN)
Table 31 Global Fertility Epigenetic Benchmarking Market Outlook, By Academic and Research Institutes (2024-2032) ($MN)
Table 32 Global Fertility Epigenetic Benchmarking Market Outlook, By Pharmaceutical and Biotechnology Companies (2024-2032) ($MN)
Table 33 Global Fertility Epigenetic Benchmarking Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
Table 34 Global Fertility Epigenetic Benchmarking Market Outlook, By Contract Research Organizations (CROs) (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

Table of Contents

200 Pages
1 Executive Summary 2 Preface 2.1 Abstract 2.2 Stake Holders 2.3 Research Scope 2.4 Research Methodology 2.4.1 Data Mining 2.4.2 Data Analysis 2.4.3 Data Validation 2.4.4 Research Approach 2.5 Research Sources 2.5.1 Primary Research Sources 2.5.2 Secondary Research Sources 2.5.3 Assumptions 3 Market Trend Analysis 3.1 Introduction 3.2 Drivers 3.3 Restraints 3.4 Opportunities 3.5 Threats 3.6 Technology Analysis 3.7 Application Analysis 3.8 End User Analysis 3.9 Emerging Markets 3.10 Impact of Covid-19 4 Porters Five Force Analysis 4.1 Bargaining power of suppliers 4.2 Bargaining power of buyers 4.3 Threat of substitutes 4.4 Threat of new entrants 4.5 Competitive rivalry 5 Global Fertility Epigenetic Benchmarking Market, By Component 5.1 Introduction 5.2 Products 5.2.1 Kits and Reagents 5.2.2 Instruments and Accessories 5.3 Services 5.3.1 DNA Methylation Analysis 5.3.2 Histone Modification Analysis 5.3.3 Non-coding RNA Analysis 5.3.4 Chromatin Structure Analysis 6 Global Fertility Epigenetic Benchmarking Market, By Technology 6.1 Introduction 6.2 DNA Methylation 6.2.1 Bisulfite Sequencing 6.2.2 Methylated DNA Immunoprecipitation Sequencing (MeDIP-Seq) 6.2.3 Other DNA Methylation Technologies 6.3 Histone Modification 6.3.1 Chromatin Immunoprecipitation (ChIP) 6.3.2 Histone Methylation Analysis 6.3.3 Histone Acetylation Analysis 6.4 RNA Sequencing 7 Global Fertility Epigenetic Benchmarking Market, By Application 7.1 Introduction 7.2 Male Infertility 7.3 Female Infertility 7.4 Assisted Reproductive Technology (ART) 7.4.1 In Vitro Fertilization (IVF) 7.4.2 Intracytoplasmic Sperm Injection (ICSI) 7.4.3 Preimplantation Genetic Testing (PGT) 7.5 Predictive Diagnostics and Prognostics 8 Global Fertility Epigenetic Benchmarking Market, By End User 8.1 Introduction 8.2 Fertility Clinics and Hospitals 8.3 Academic and Research Institutes 8.4 Pharmaceutical and Biotechnology Companies 8.5 Diagnostic Laboratories 8.6 Contract Research Organizations (CROs) 9 Global Fertility Epigenetic Benchmarking Market, By Geography 9.1 Introduction 9.2 North America 9.2.1 US 9.2.2 Canada 9.2.3 Mexico 9.3 Europe 9.3.1 Germany 9.3.2 UK 9.3.3 Italy 9.3.4 France 9.3.5 Spain 9.3.6 Rest of Europe 9.4 Asia Pacific 9.4.1 Japan 9.4.2 China 9.4.3 India 9.4.4 Australia 9.4.5 New Zealand 9.4.6 South Korea 9.4.7 Rest of Asia Pacific 9.5 South America 9.5.1 Argentina 9.5.2 Brazil 9.5.3 Chile 9.5.4 Rest of South America 9.6 Middle East & Africa 9.6.1 Saudi Arabia 9.6.2 UAE 9.6.3 Qatar 9.6.4 South Africa 9.6.5 Rest of Middle East & Africa 10 Key Developments 10.1 Agreements, Partnerships, Collaborations and Joint Ventures 10.2 Acquisitions & Mergers 10.3 New Product Launch 10.4 Expansions 10.5 Other Key Strategies 11 Company Profiling 11.1 Illumina 11.2 Thermo Fisher Scientific 11.3 Merck KGaA 11.4 QIAGEN 11.5 F. Hoffmann-La Roche 11.6 PacBio 11.7 Danaher 11.8 Bio-Rad Laboratories 11.9 Promega 11.10 New England Biolabs 11.11 Zymo Research 11.12 Hologic 11.13 Active Motif 11.14 Chroma Medicine 11.15 CooperSurgical 11.16 Inherent Biosciences 11.17 Vitrolife 11.18 Ferring Pharmaceuticals List of Tables Table 1 Global Fertility Epigenetic Benchmarking Market Outlook, By Region (2024-2032) ($MN) Table 2 Global Fertility Epigenetic Benchmarking Market Outlook, By Component (2024-2032) ($MN) Table 3 Global Fertility Epigenetic Benchmarking Market Outlook, By Products (2024-2032) ($MN) Table 4 Global Fertility Epigenetic Benchmarking Market Outlook, By Kits and Reagents (2024-2032) ($MN) Table 5 Global Fertility Epigenetic Benchmarking Market Outlook, By Instruments and Accessories (2024-2032) ($MN) Table 6 Global Fertility Epigenetic Benchmarking Market Outlook, By Services (2024-2032) ($MN) Table 7 Global Fertility Epigenetic Benchmarking Market Outlook, By DNA Methylation Analysis (2024-2032) ($MN) Table 8 Global Fertility Epigenetic Benchmarking Market Outlook, By Histone Modification Analysis (2024-2032) ($MN) Table 9 Global Fertility Epigenetic Benchmarking Market Outlook, By Non-coding RNA Analysis (2024-2032) ($MN) Table 10 Global Fertility Epigenetic Benchmarking Market Outlook, By Chromatin Structure Analysis (2024-2032) ($MN) Table 11 Global Fertility Epigenetic Benchmarking Market Outlook, By Technology (2024-2032) ($MN) Table 12 Global Fertility Epigenetic Benchmarking Market Outlook, By DNA Methylation (2024-2032) ($MN) Table 13 Global Fertility Epigenetic Benchmarking Market Outlook, By Bisulfite Sequencing (2024-2032) ($MN) Table 14 Global Fertility Epigenetic Benchmarking Market Outlook, By Methylated DNA Immunoprecipitation Sequencing (MeDIP-Seq) (2024-2032) ($MN) Table 15 Global Fertility Epigenetic Benchmarking Market Outlook, By Other DNA Methylation Technologies (2024-2032) ($MN) Table 16 Global Fertility Epigenetic Benchmarking Market Outlook, By Histone Modification (2024-2032) ($MN) Table 17 Global Fertility Epigenetic Benchmarking Market Outlook, By Chromatin Immunoprecipitation (ChIP) (2024-2032) ($MN) Table 18 Global Fertility Epigenetic Benchmarking Market Outlook, By Histone Methylation Analysis (2024-2032) ($MN) Table 19 Global Fertility Epigenetic Benchmarking Market Outlook, By Histone Acetylation Analysis (2024-2032) ($MN) Table 20 Global Fertility Epigenetic Benchmarking Market Outlook, By RNA Sequencing (2024-2032) ($MN) Table 21 Global Fertility Epigenetic Benchmarking Market Outlook, By Application (2024-2032) ($MN) Table 22 Global Fertility Epigenetic Benchmarking Market Outlook, By Male Infertility (2024-2032) ($MN) Table 23 Global Fertility Epigenetic Benchmarking Market Outlook, By Female Infertility (2024-2032) ($MN) Table 24 Global Fertility Epigenetic Benchmarking Market Outlook, By Assisted Reproductive Technology (ART) (2024-2032) ($MN) Table 25 Global Fertility Epigenetic Benchmarking Market Outlook, By In Vitro Fertilization (IVF) (2024-2032) ($MN) Table 26 Global Fertility Epigenetic Benchmarking Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2024-2032) ($MN) Table 27 Global Fertility Epigenetic Benchmarking Market Outlook, By Preimplantation Genetic Testing (PGT) (2024-2032) ($MN) Table 28 Global Fertility Epigenetic Benchmarking Market Outlook, By Predictive Diagnostics and Prognostics (2024-2032) ($MN) Table 29 Global Fertility Epigenetic Benchmarking Market Outlook, By End User (2024-2032) ($MN) Table 30 Global Fertility Epigenetic Benchmarking Market Outlook, By Fertility Clinics and Hospitals (2024-2032) ($MN) Table 31 Global Fertility Epigenetic Benchmarking Market Outlook, By Academic and Research Institutes (2024-2032) ($MN) Table 32 Global Fertility Epigenetic Benchmarking Market Outlook, By Pharmaceutical and Biotechnology Companies (2024-2032) ($MN) Table 33 Global Fertility Epigenetic Benchmarking Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN) Table 34 Global Fertility Epigenetic Benchmarking Market Outlook, By Contract Research Organizations (CROs) (2024-2032) ($MN) Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.